Category

Uncategorized
Economist Garima Kapoor anticipates a 50 basis point rate cut by the RBI in FY26, citing easing inflation and robust public capex. She highlights deregulation initiatives as unique, while noting risks from the external sector and potential impacts on rural demand. Kapoor believes the RBI is strategically holding its ground amid global uncertainties.
Read More
Tech Mahindra is poised for a double-digit sequential improvement in its September quarter net profit, with estimates ranging from 11.4% to 19.5% growth. Revenue is also expected to see a modest uptick, driven by large deal ramp-ups. Brokerages anticipate a strong recovery in EBIT and margins due to cost controls and operational efficiency.
Read More
Market experts Kunal Bothra and Ashish Chaturmohta are identifying top stock picks for Diwali 2025. These selections span telecom, aviation, energy, and banking. Bharti Hexacom and Petronet LNG are recommended for short-term gains. IndiGo is a long-term prospect due to India’s travel boom. ICICI Bank is favored for its financial strength and digital advancements. Selective...
Read More
Radhika Gupta of Edelweiss Mutual Fund sees a bright future for India’s equity market. She believes domestic demand will drive growth in the coming year. SIP flows are strong, and consumption is expected to rebound. Sectors like hospitals, hotels, and capital markets are poised for long-term gains. Earnings are set to improve, signaling a positive...
Read More
India’s Nifty index has not reached a new peak for over a year. However, market experts remain positive, citing government initiatives and potential economic support. A key factor for a turnaround is expected to be a rebound in corporate earnings.
Read More
As long as the stock is priced above the 200-day SMA on the daily time frame, it is generally considered to be an overall uptrend.
Read More
We have collated a list of recommendations from top brokerage firms from ETNow and other sources.
Read More
Canara Robeco AMC’s IPO share allotment is expected today following a robust investor response, with the issue set to list on October 16. The IPO was subscribed 9.74 times overall, driven by strong demand from Qualified Institutional Buyers. Investors are keen to check their allocation status online via the registrar or BSE portal.
Read More
Rubicon Research’s Rs 1,377 crore IPO concluded with strong investor demand, oversubscribing 109.35 times. The share allotment is scheduled for October 14, with the company set to list on the BSE and NSE on October 16. The pharmaceutical firm’s robust financial performance and differentiated product portfolio are driving positive market sentiment.
Read More
1 1,211 1,212 1,213 1,214 1,215 1,534

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases